Carefirst of Maryland, Inc. et al v. Amgen, Inc. et al

Track this case

Case overview

Case Number:

2:24-cv-00484

Court:

Virginia Eastern

Nature of Suit:

Anti-Trust

Multi Party Litigation:

Class Action

Judge:

Arenda L. Wright Allen

Firms

Companies

Sectors & Industries:

  1. January 09, 2025

    Amgen Says Enbrel Protected By Legit Patents, Rulings

    Amgen has asked a Virginia federal judge to permanently toss the latest version of a proposed class action accusing it of illegally entrenching and expanding patent rights to stave off cheaper competition for Enbrel, arguing the blockbuster arthritis treatment is protected by legitimate patents and court rulings of validity.

  2. August 07, 2024

    Amgen Waged Lawfare To Overcharge For Drug, Suit Claims

    Maryland-based independent licensees of the Blue Cross Blue Shield Association claim pharmaceutical giant Amgen Inc. and its subsidiaries have engaged in unlawful monopolistic practices that have inflated the cost of the blockbuster drug Enbrel.